GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...

By Yahoo! Finance | Oct 31, 2024 at 03:05 AM EST

GSK anticipates profitable growth in 2025, led by Specialty Medicines. Sales of Shingrix in China face challenges, with flexibility in the Zhifei contract. Arexvy sales show promise internationally, with a focus on managing pharmacy congestion.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.